Company News
Dr. Reddy's Semaglutide API Impurity Halts Supply
Dr. Reddy's disclosed a manufacturing impurity in scaled-up Semaglutide API batches, halting commercial supply for approximately three months.
The company expects a potential inventory write-down and
